ArticleBMC anesthesiology2026
Tranexamic acid use and the risk of postoperative delirium after spine surgery: a retrospective cohort study.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative delirium (POD) is a common complication after major surgery and has been linked to perioperative neuroinflammation. Tranexamic acid (TXA), an antifibrinolytic agent, may influence inflammatory pathways, but its effect on POD remains unclear. This post hoc analysis investigated the association between intraoperative TXA administration, POD, and perioperative biomarkers of inflammation and neuronal injury.
methodsThis post hoc analysis of the prospective CONFESS cohort included patients aged ≥ 60 years undergoing elective spine surgery. POD was assessed using the Nursing Delirium Screening Scale and DSM-5 criteria. Multivariable logistic regression evaluated the association between TXA and POD. Perioperative changes in IL-6, S100β, sTREM2, and Gasdermin D were analyzed using repeated-measures ANOVA. False discovery rate correction was applied for multiple testing.
resultsAmong 93 enrolled patients, POD screening was available for 89, of whom 42 (47.2%) received intraoperative TXA. Overall, 17 patients (18.7%) developed POD, including 12 (70.6%) who had received TXA. In univariate analysis, TXA administration was associated with POD (OR 3.36, 95% CI 1.07-10.54; p = 0.035), but this association was not maintained after multivariable adjustment and false discovery rate correction. Gasdermin D was the only biomarker independently associated with POD (OR = 0.212 [0.046-0.974], p = 0.046). Significant perioperative biomarker changes were observed, with a significant time × treatment interaction only for IL-6 (p = 0.028). In exploratory subgroup analyses, TXA exposure was associated with a higher incidence of POD among patients aged ≥ 75 years, whereas no association was observed in younger patients.
conclusionIn this exploratory post hoc analysis, intraoperative TXA administration was not independently associated with postoperative delirium after adjustment for relevant confounders. Although perioperative biomarker dynamics reflected the expected inflammatory response to surgery, only IL-6 demonstrated differential temporal changes according to TXA exposure, while Gasdermin D emerged as a potential biomarker associated with POD. Given the observational design, limited sample size, and small number of delirium events, these findings should be regarded as hypothesis-generating. Larger randomized studies using standardized TXA protocols are warranted to clarify the relationship between TXA, perioperative neuroinflammation, and postoperative delirium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.